Ghazi Kashmolah - 25 Aug 2022 Form 4 Insider Report for Lucira Health, Inc.

Role
Ex VP & Chief Quality Officer
Signature
/s/ Dan George, Attorney-in-Fact for Ghazi Kashmolah
Issuer symbol
N/A
Transactions as of
25 Aug 2022
Net transactions value
-$2,895
Form type
4
Filing time
29 Aug 2022, 20:19:21 UTC
Previous filing
24 Aug 2022
Next filing
18 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LHDXQ Common Stock Sale $2,895 -1,500 -0.81% $1.93* 184,677 25 Aug 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 5,420 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan on August 19, 2022.